Tag: concerns

Posted on

Are children more likely to share mental health concerns with a robot?

Are children more likely to share mental health concerns with a robot?

A silhouette of a person against a green backdrop of binary codeShare on Pinterest
New research shows that a “child-like robot” was able to detect mental health concerns in children with more accuracy than humans. Aitor Diago/Getty Images
  • The growing youth mental health crisis highlights a need for early detection and treatment of mental health disorders.
  • A new study by University of Cambridge researchers found that socially assistive robots (SARs) could serve as a potential diagnostic tool for mental health.
  • According to the researchers, the study is the first time robots have been used to asses children’s mental well-being.
  • The study shows that robots were more likely to identify cases of well-being anomalies than self-reports filled by children or reports made by their parents.
  • Still, researchers did not use robots to deliver mental health interventions, but rather, to detect and diagnose children’s mental health concerns.

Even before the pandemic, an estimated 4.4{cfdf3f5372635aeb15fd3e2aecc7cb5d7150695e02bd72e0a44f1581164ad809} of children (about 2.7 million) between the ages of three and 17 had been diagnosed with depression in the United States, according to the National Survey of Children’s Health. The same survey found about 9.4{cfdf3f5372635aeb15fd3e2aecc7cb5d7150695e02bd72e0a44f1581164ad809} (about 5.8 million) of children had been diagnosed with anxiety.

Experts believe that stress from COVID-19 has led to increased depression and anxiety in young people.

Mental health-related emergency room visits for children ages 5 to 11 increased by 24{cfdf3f5372635aeb15fd3e2aecc7cb5d7150695e02bd72e0a44f1581164ad809} in 2020 compared to the year prior, according to a report from the Centers for Disease Control and Prevention (CDC). Among children between the ages of 12 and 17, visits increased by 31{cfdf3f5372635aeb15fd3e2aecc7cb5d7150695e02bd72e0a44f1581164ad809}.

At the same time, adequate mental health care and access are still lacking in the U.S.

Nearly 91 million Americans live in regions with shortages of mental health providers, according to the Substance Abuse and Mental Health Services Administration, which estimates a minimum of 1,846 psychiatrists and 5,931 other practitioners are needed to fill the gap.

Recently, a group of researchers from the University of Cambridge studied the effects of socially assistive robots (SARs), which could potentially serve as an assessment and diagnostic tool in areas where mental health professionals are in short supply.

Their work was presented this week at the 2022 IEEE International Conference on Robots and Human Interactive Communication in Naples, Italy.

For the study, researchers selected 28 children from Cambridgeshire, England, ages 8 to 13 years old. Among the participants, 21 were female and 7 were male with an average age of 9.5.

Children who had already been diagnosed with neurological or psychological disorders were excluded from the research.

First, the participants answered about their well-being on an online questionnaire. Additionally, parents or guardians answered a questionnaire about the well-being of their children.

Later, the young participants spent 45 minutes with a Nao robot, created by SoftBank Robotics. The robot then administered the Short Mood and Feelings Questionnaire, which measures symptoms of depression, and the Revised Child Anxiety and Depression Scale.

Additionally, the robot asked the children about happy and sad memories they experienced over the last week and administered a task where children were shown pictures and then asked questions about them.

The researchers found that questionnaires conducted by robots were more likely to identify cases of well-being anomalies than the children’s online self-reports or parent or guardian reports.

Some participants shared information with the robot that they did not share via self-report.

Study co-author Prof. Hatice Gunes, Ph.D., a professor of affective intelligence and robotics and head of the Affective Intelligence and Robotics Lab at the University of Cambridge, explained to Medical News Today that among participants, “the group that might have some well-being related concerns” were more likely to provide negative response ratings during the robot-led questionnaires.

“The interesting finding here is when they interact with the robot their responses become more negative,” Prof. Gunes noted.

Socially assistive robots have previously demonstrated potential as a tool to improve the accessibility of care, the researchers explain in their paper. For instance, a 2020 study illustrated that robots may be helpful in assessing risk factors for autism spectrum disorder (ASD).

“Robots have been used for various tasks — and they’ve been shown to be effective in certain things because they have this physical embodiment, unlike a mobile phone or a virtual character or even videos,” Prof. Gunes said.

And despite the potential dangers of allowing a child too much time with an electronic device, working one-on-one with a robot is different from screentime, Prof. Gunes noted.

“This is a physical interaction, right? So, it’s not virtual. It’s not a video — they’re physically interacting with a physical entity,” she said.

Prof. Gunes also pointed to a key aspect of the study: the “child-like robot” used for the research was less than 2 feet tall.

“Here we have a child-looking and child-sounding robot. “In such situations, children actually see the robot more as a peer. So, it’s not an adult that is trying to get some information out of them.”

– Prof. Hatice Gunes, Ph.D., professor of affective intelligence and robotics at the University of Cambridge

Diane Hodge, Ph.D., LCSW, director of the school of social work at Radford University in Virginia, said she’s used puppets and dolls to help make her pediatric clients feel more at ease while she worked as a clinical social worker earlier in her career.

Robots, she told MNT, are the 21st-century equivalent of those puppets.

“I’m all about technology that really enhances and helps people,” Hodge said. “More kids today are just so used to it that they expect it.”

Hodge also pointed out that in the study, the researchers did not use a robot to deliver mental health care interventions, but rather, to assess the well-being of children. “This is just to get people access,” she said.

Hodge also highlighted how the Nao robot was able to successfully identify more “well-being-related anomalies” in children compared to those revealed by humans. “[That] shows that if we had done nothing, right, they wouldn’t have caught that,” she said.

According to Prof. Gunes, her research interests evolved after having a baby in 2018. “I think I became more sensitive to child-related issues and their well-being,” she said.

In the future, Prof. Gunes said the researchers hope to study how children respond to interacting with a diagnostic robot over video chat.

Already, researchers are preparing to conduct a study similar to the one they presented at the conference only with a more equal ratio of male and female participants, according to Prof. Gunes.

“We want to see actually if the findings are consistent across genders,” she said.

Posted on

Biden’s support is fading as concerns over the economy and Covid grow, CNBC survey finds

President Joe Biden’s approval ranking slipped deeply underwater in the CNBC All-The us Economic Study as Us citizens soured on his financial leadership, missing some self-confidence in his managing of the coronavirus, and grew increasingly worried about inflation and offer shortages.

Just 41{cfdf3f5372635aeb15fd3e2aecc7cb5d7150695e02bd72e0a44f1581164ad809} of the general public approve of Biden’s managing of the presidency, in contrast with 52{cfdf3f5372635aeb15fd3e2aecc7cb5d7150695e02bd72e0a44f1581164ad809} who disapprove. The poll of 800 Us residents, executed Oct. 14-17, has a margin of error of 3.5{cfdf3f5372635aeb15fd3e2aecc7cb5d7150695e02bd72e0a44f1581164ad809}.

Biden’s damaging 11-issue internet score compared with a favourable 3 details in the July study, when 48{cfdf3f5372635aeb15fd3e2aecc7cb5d7150695e02bd72e0a44f1581164ad809} accredited and 45{cfdf3f5372635aeb15fd3e2aecc7cb5d7150695e02bd72e0a44f1581164ad809} disapproved.

Powering the decrease is a surge in negative views of his dealing with of the overall economy, with just 40{cfdf3f5372635aeb15fd3e2aecc7cb5d7150695e02bd72e0a44f1581164ad809} approving and 54{cfdf3f5372635aeb15fd3e2aecc7cb5d7150695e02bd72e0a44f1581164ad809} disapproving, a 7-position increase from July.

A bare the vast majority of Us residents nonetheless approve his dealing with of the virus, but the margin narrowed considerably. Fifty per cent now approve compared with 53{cfdf3f5372635aeb15fd3e2aecc7cb5d7150695e02bd72e0a44f1581164ad809} in July, and 45{cfdf3f5372635aeb15fd3e2aecc7cb5d7150695e02bd72e0a44f1581164ad809} disapprove, in contrast with just 38{cfdf3f5372635aeb15fd3e2aecc7cb5d7150695e02bd72e0a44f1581164ad809}.

The president’s numbers are declining as considerations about the economy, inflation and supply shortages rise sharply.

Inflation now ties with the coronavirus as the largest worry for People in america, up 16 details from the prior study. A plurality of 47{cfdf3f5372635aeb15fd3e2aecc7cb5d7150695e02bd72e0a44f1581164ad809} of the general public feel there will be a recession in the following yr, up 13 details from when the concern was last questioned in 2019.

“Very last quarter, the financial quantities were flashing yellow for Biden, but now that’s intensified and the light is flashing pink, and it really is accompanied by multiple blaring sirens,” reported Micah Roberts, lover at Public Impression Techniques, the Republican pollster for the survey.

Recession anxieties arrive with more and more damaging sights about the present-day and potential point out of the economy: 46{cfdf3f5372635aeb15fd3e2aecc7cb5d7150695e02bd72e0a44f1581164ad809} say the economy will get worse in the yr ahead, the most in the 13-yr background of the poll and 79{cfdf3f5372635aeb15fd3e2aecc7cb5d7150695e02bd72e0a44f1581164ad809} judge the overall economy as just fair or poor, the most given that 2014.

U.S. President Joe Biden holds a assembly with company leaders and CEOs about the financial debt restrict at the White Home in Washington, U.S., October 6, 2021.

Kevin Lamarque | Reuters

Just 31{cfdf3f5372635aeb15fd3e2aecc7cb5d7150695e02bd72e0a44f1581164ad809} say now is a great time to commit in shares, the cheapest because 2016.

Jay Campbell, associate at Hart Exploration Associates, the Democratic pollster for the study, points out that Biden’s figures on the coronavirus are especially worrisome considering the fact that he thinks Biden’s perceived capacity to deal with the pandemic was a big rationale for his election.

“If the economic system doesn’t get back on keep track of, and the Coronavirus will not reverse training course at some position shortly, then this is a presidency that is heading to be in true difficulty,” he said.

The survey evidently exhibits Us citizens noticing the offer and labor shortages that are plaguing corporations. Some 60{cfdf3f5372635aeb15fd3e2aecc7cb5d7150695e02bd72e0a44f1581164ad809} of the public say merchandise that have been as soon as effortless to acquire are in small offer, such as food stuff and groceries, paper solutions, and cleaning solutions.

Also, 66{cfdf3f5372635aeb15fd3e2aecc7cb5d7150695e02bd72e0a44f1581164ad809} surface to have discovered labor shortages, stating they have experienced outlets shut on odd times or at strange several hours when they normally would be open.

The a person modest piece of good news for the president in the poll is that a plurality of People supports a program in advance of Congress that would increase spending for boy or girl care, clear power, group colleges and long-term treatment for the elderly.

The survey uncovered 41{cfdf3f5372635aeb15fd3e2aecc7cb5d7150695e02bd72e0a44f1581164ad809} of respondents assist the evaluate, 30{cfdf3f5372635aeb15fd3e2aecc7cb5d7150695e02bd72e0a44f1581164ad809} oppose it and a significant 29{cfdf3f5372635aeb15fd3e2aecc7cb5d7150695e02bd72e0a44f1581164ad809} say they really don’t know ample to answer. A 51{cfdf3f5372635aeb15fd3e2aecc7cb5d7150695e02bd72e0a44f1581164ad809} vast majority guidance the program when advised the charge of the program is between $1.5 and $2.2 trillion. And 57{cfdf3f5372635aeb15fd3e2aecc7cb5d7150695e02bd72e0a44f1581164ad809} back the bill when informed it will be paid for by growing taxes on organizations and all those earning much more than $400,000 a calendar year.

Come to be a smarter investor with CNBC Professional.
Get stock picks, analyst calls, exceptional interviews and accessibility to CNBC Television.
Signal up to start a cost-free demo nowadays.

Posted on

What we know about molnupiravir: Data and safety concerns

In the search for effective COVID-19 treatments, many drugs have failed to live up to their early promise. In a recent trial, seen as an important advance, the oral antiviral drug molnupiravir halved the risk of hospital admissions and deaths from COVID-19. Medical News Today explored the evidence to see whether this optimism is justified.

Share on Pinterest
The experimental drug molnupiravir has brought fresh hope in the fight against COVID-19. But what do we know about it so far? Image credit: Jordan Lye/Getty Images

A global trial, led by the pharmaceutical company Merck — known as MSD outside the United States and Canada — and Ridgeback Therapeutics, has found that the companies’ experimental antiviral drug molnupiravir reduces the risk of hospital admission or death from COVID-19 by approximately 50{cfdf3f5372635aeb15fd3e2aecc7cb5d7150695e02bd72e0a44f1581164ad809}.

Although this was a small-scale trial, these positive results have led to countries rushing to sign up for supplies of the drug.

In the randomized, phase 3 trial, scientists gave molnupiravir or a placebo to 775 people. All the participants had tested positive for SARS-CoV-2 infections and experienced mild to moderate COVID-19 symptoms that had begun no more than 5 days earlier.

Stay informed with live updates on the current COVID-19 outbreak and visit our coronavirus hub for more advice on prevention and treatment.

Every participant had at least one risk factor for severe COVID-19 but had not been admitted to a hospital. Risk factors included obesity, an age of over 60 years, diabetes, and heart disease.

The scientists allocated each of the 775 participants randomly to one of two groups. One group received molnupiravir and the other a placebo. The participants took the capsules twice a day for 5 days.

Of the 385 patients taking molnupiravir, 28 were admitted to a hospital, compared with 53 of those in the placebo group. Eight of the placebo group participants died, while all those receiving the antiviral were alive at the end of the 29-day study period.

Recruitment into the study has now been halted because of these overwhelmingly positive results. The manufacturer, Merck, is applying for emergency use authorization from the Food and Drug Administration (FDA).

The Singapore health ministry has signed a purchase agreement for molnupiravir, and the European Medicines Agency is considering a rolling review of the drug.

“With these compelling results, we are optimistic that molnupiravir can become an important medicine as part of the global effort to fight the pandemic.”

– Robert M. Davis, chief executive officer and president of Merck

Merck plans to produce 10 million courses of the treatment in 2021 and more in 2022.

The study results have been greeted with optimism. Prof. Tim Spector, a professor of genetic epidemiology at King’s College London, told MNT: “This is an exciting result from a randomized study of 775 patients, showing major effects in reducing severity and death from a simple pill given at the onset of infection.”

Molnupiravir belongs to a class of antivirals called mutagenic ribonucleosides. These change the viral genetic material and introduce errors to prevent replication and transcription of the viral genome.

Inside the host cell, molnupiravir is converted to molnupiravir triphosphate. When the virus tries to replicate, molnupiravir triphosphate is incorporated into the viral RNA instead of the nucleoside cytidine, causing a mutation.

The mutation stops the virus from replicating. This keeps numbers of the virus in the body low and should reduce the severity of the disease.

Other drugs that interfere with viral RNA have shown potential as COVID-19 treatments. Remdesivir, an intravenously administered drug that interferes with an enzyme essential for replicating viral RNA, showed early promise.

Although the FDA has granted approval to remdesivir, the World Health Organization (WHO) no longer recommends it as a COVID-19 treatment, due to insufficient evidence to support its use.

The advantage of molnupiravir is that, unlike all the other potential treatments so far, it is an oral tablet that a person can take outside a clinical setting. At a projected cost of around $700 per person for a 5-day course, it is also more affordable than other drugs. However, this cost is still likely to limit its use.

“Antiviral treatments that can be taken at home to keep people with COVID-19 out of the hospital are critically needed. We are very encouraged by the results from the interim analysis and hope molnupiravir, if authorized for use, can make a profound impact in controlling the pandemic.”

– Wendy Holman, chief executive officer of Ridgeback Biotherapeutics

Prof. Sir Peter Horby, a professor of emerging infectious diseases and global health at the University of Oxford, is largely optimistic: “A safe, affordable, and effective antiviral would be a huge advance in the fight against COVID.”

However, he retained a note of caution: “It is important to remember that the absolute risks were 14{cfdf3f5372635aeb15fd3e2aecc7cb5d7150695e02bd72e0a44f1581164ad809} reduced to 7{cfdf3f5372635aeb15fd3e2aecc7cb5d7150695e02bd72e0a44f1581164ad809}, so quite a lot of people need to be treated to prevent one hospitalization or death. This means the drug needs to be very safe and affordable.”

This caution was echoed by Prof. William Schaffner, a professor of infectious diseases at the Vanderbilt University School of Medicine, who said: “In the studies in very high risk patients, it reduced the level of serious disease by only half. It’s not a magic pill.”

He added: “In research settings, you can ensure that people take the pill as directed. In practice, there is usually a lower success rate than in clinical trials.”

Dr. Peter English, a retired consultant in communicable disease and a past chair of the British Medical Association Public Health Medicine Committee, has also expressed doubts: “The problem for antivirals like Merck’s molnupiravir is that they would have to be used before people are (usually) deemed ill enough to need anything other than symptomatic self-care treatment.”

“Unless an antiviral medication could be made so cheap and so safe that it can be used ‘on spec’ by people who might have COVID-19, [it is] unlikely to be widely useful,” he adds.

Despite widespread optimism following the study results, some experts have raised concerns about the safety of a drug that works by causing mutations.

As molnupiravir causes viral RNA to mutate, there are concerns that it might cause mutations in host cells, as well. One study in animal cell cultures found mutations in cells treated with molnupiravir.

This has led to worries that the drug might cause cancers or birth abnormalities. The authors of the animal cell study recommend that this mutagenic potential be assessed in vivo, focusing on rapidly dividing cells. Additionally, they recommend monitoring to assess potential genotoxic side effects.

“It’s worth noting that people involved in the trial were instructed to abstain from heterosexual sex or use contraception. While this is routine practice with some other medicines, such as cancer chemotherapy, it suggests that the drug has the potential to cause birth defects should someone become pregnant.”

– Dr. Simon Clarke, associate professor of cellular microbiology at the University of Reading

Prof. Schaffner was less concerned about the possible genetic implications: “The FDA would certainly not have permitted clinical trials in humans if they thought there were any reasonable danger. […] Animal studies showed no adverse effects.”

In this trial, molnupiravir was effective against all variants, including the Delta variant, which was shown in a recent study to have a 235{cfdf3f5372635aeb15fd3e2aecc7cb5d7150695e02bd72e0a44f1581164ad809} increased risk of intensive care unit admission, compared with the original variant.

These positive results applied to people who had received molnupiravir soon after the onset of mild to moderate symptoms. A previous trial showed no benefit in giving the drug to patients already in hospital with COVID-19.

As an early treatment, molnupiravir could, Prof. Schaffner agrees, “offer another opportunity to prevent serious disease.”

“Although [this trial] had relatively small numbers analysed (fewer than 400 per group), it had much better results than the study done in hospitalized patients. It approximately halved the rate of hospitalization and notably reduced the number of deaths. Preventing the virus from replicating at an early stage seems very beneficial.”

– Prof. Stephen Evans, professor of pharmacoepidemiology at the London School of Hygiene & Tropical Medicine

So, is molnupiravir the drug we have been waiting for to bring COVID-19 under control? Perhaps, but the evidence is not yet conclusive.

Prof. Spector is among those keen to see more trial results. “We are told there were few side effects, but it would be good to know more details and see a full peer-reviewed publication,” he said. “But if this pans out, it will be a major game-changer for [COVID-19] treatment and possibly other viruses.”

For live updates on the latest developments regarding the novel coronavirus and COVID-19, click here.

Posted on

October 13 News Updates: Air India Unions raise concerns about cash, leave, medical benefits, accommodation of employees & arrears

!1 New UpdateClick here for latest updates

Wrap Up: All you need to know

  • Wipro Q2 consolidated profit rises by 17{cfdf3f5372635aeb15fd3e2aecc7cb5d7150695e02bd72e0a44f1581164ad809} to Rs 2,930.6 cr, revenue up at Rs 19,667.4 cr
  • Infosys Q2 net profit up 11.9 pc at Rs 5,421 crore; revenue rises 20.5 pc to Rs 29,602 crore: Co filing
  • Govt scraps basic customs duty on crude varieties of palm, soyabean and sunflower oil till March 31; also cuts agri cess
  • Govt withdraws travel advisory that added COVID-19 related additional checks, restrictions on those arriving from the UK
  • Shardul Thakur replaces all-rounder Axar Patel in India’s main squad for T20 World Cup. Patel placed in list of stand-by players: BCCI
  • Kolkata Knight Riders beat Delhi Capitals by 3 wickets in second IPL qualifier, set up title clash with Chennai Super Kings
  • Cumulative COVID-19 vaccine doses administered in India has crossed 96 crore with more than 32 lakh jabs administered today
  • All colleges and universities in Maharashtra can conduct physical classes from October 20
  • Delhi records 31 fresh COVID-19 cases, zero death; positivity rate at 0.05 per cent: Health bulletin

Deity at Sri Kanyaka Parameswari Temple decorated with gold

IBM in talks with states to expand ‘SkillBuild’ initiative in India

IT company IBM on Wednesday said it is in talks with several states in India to expand its ‘SkillsBuild’ initiative.

Government of Puducherry declares holidays on October 15 and 16 for govt, govt-aided and private schools on account of Vijayadasami in the UT and Karaikal regions.

IPL2021, Qualifier 2: Kolkata Knight Riders (136/7) beat Delhi Capitals (135/5) by three wickets, to face Chennai Super Kings in the final

36 IPS, 14 PPS officers transferred in Punjab

Mexico tells WHO to act without “ideology” on certifying COVID-19 vaccines

Mortal remains of Sepoy Vaisakh H reaches Thiruvananthapuram

Union Housing and Urban Affairs Ministry says 1,183 of 1,224 pressure swing adsorption (PSA) oxygen generation plants being funded by PM Cares Fund have been commissioned across country so far

Air India Unions have demanded that employees should be allowed to stay in airline flats till monetization or at least for a year as Tatas are giving a one-year employment guarantee

Air India Unions in a joint letter to Secretary, Ministry of Civil Aviation raise concerns about cash, leave, medical benefits, accommodation of employees & arrears

Ghaziabad: Many people feared injured after a bus falls from Bhatia Modh flyover; Police present at the spot, rescue operation underway

Israel FM Lapid, with Blinken at his side, says his country ‘reserves right’ to use force on Iran

Power System Operation Corporation Limited (POSOCO) has reported that the total capacity of units under outage due to low coal stocks has reduced from 11 GW on 12th October to 6 GW on 13th October: Ministry of Power

BJP leaders in Madhya Pradesh’s Indore send air tickets to Congress leaders Priyanka Gandhi Vadra and Rahul Gandhi, ask them to visit their party-ruled Rajasthan, where atrocities have been allegedly committed on Dalits

National Commission for Schedules Castes chairman Vijay Sampla directs officials to take swift action against those who thrashed a Dalit man to death in Rajasthan’s Hanumangarh district

Blue Origin capsule lands on Earth after space flight with Star Trek’s Shatner

Telangana logs 184 cases, 1 death; 2 Cr people have got first dose of vaccine

Letter from Delhi Police received with names of 32 jail officials found prima facie complicit in the Unitech matter

Out of 32 personnel, 30 regular employees suspended & 2 contractural employees terminated: Prison officials

Former Prime Minister Dr. Manmohan Singh admitted to All India Institute of Medical Sciences, Delhi for evaluation of fever; his condition is stable: AIIMS officials

India’s COVID-19 vaccination coverage crosses 96.78 crore with more than 32 lakh vaccine doses have been administered till 7 pm today: Government of India

Priyank Kanoongo re-appointed as chairperson of the National Commission for Protection of Child Rights for a period of three years

Former BJP MP Kirit Somaiya claims searches conducted by Income Tax officials on premises linked to family members of Maharashtra Deputy CM Ajit Pawar are ‘biggest’ such raids in India

The maximum demand of Delhi was 4707 MW (peak) and 101.5 MU (Energy) on 12 Oct. As per the information received from Delhi DISCOMs, there was no outage on account of power shortage, as the required amount of power was supplied to them

– Ministry of Power

India’s COVID-19 vaccination will cross landmark of 100 crore vaccine doses in a few days; country will produce over 28 crore doses in October

– Union Health Minister Mansukh Mandaviya

Chief Minister Pushkar Singh Dhami has said that on death due to COVID19, the state government will give a compensation of Rs 50,000 to the kin of the deceased: Uttarakhand Chief Minister’s Office

“Unsung Heroes of Odisha”

Tamil Nadu reports 1,280 new COVID19 cases, 19 deaths and 1,453 recoveries in the last 24 hours

active cases 15,650

COVID19: Himachal Pradesh reported 139 new cases, 68 recoveries and one death during the past 24 hours

Former Maharashtra home minister Anil Deshmukh tells Bombay HC that ED initiated proceedings against him in alleged money laundering case based on claims made by those people who themselves are accused of “heinous offences such as murder and extortion”

4 held with 66 grams of heroin in separate incidents in J-K’s Kathua

Former PM Manmohan Singh admitted to AIIMS with fever and weakness

Media Reports

At least 108 Yemen rebels dead in strikes south of Marib: Saudi-led coalition

National Investigation Agency (NIA) has arrested five more terror operatives in J&K terrorism conspiracy case during raids at two places in Srinagar earlier today: NIA

‘Samajwadi Vijay Yatra’ reaches Kanpur

President appoints the 14 advocates and judicial officers as judges of the Telangana High Court, Orissa HC and Kerala HC

Mumbai reports 481 new cases, 3 deaths and 461 recoveries in last 24 hours

COVID-19: Delhi reports 31 new cases, 58 recoveries and zero deaths in the last 24 hours; active cases 338

US consumer prices rose 5.4 percent annually in September: govt

COVID-19; 357 new positive cases, 438 recoveries and 10 deaths have been reported in Karnataka, today

Active cases 9621 and total positive cases 29,82,089

Lakhimpur Kheri violence case: Ankit Das sent to judicial custody till 22nd October

COVID19: 11,079 new cases, 123 deaths and 9,972 recoveries reported in Kerala today

Active caseload stands at 97,630

Chief of Army Staff General MM Naravane in Sri Lanka

Colleges in Maharashtra to re-open from October 20, reported ToI quoting Higher and technical education Minister Uday Samant.

NCB says it has spoken to MEA for identification of foreign nationals allegedly involved in the VIP drug bust case

Reports TIMES NOW

Cruise ship raid case: A Mumbai Court adjourns hearing for tomorrow on bail applications of Aryan Khan, Arbaaz Merchant and Munmun Dhamecha

President Ram Nath Kovind will visit Ladakh and Jammu & Kashmir on Oct 14 & 15

The coal target which was given to us by Power Ministry was 1.9 million tonnes/day & after 20th it was 2 million tonnes/day. Today, we’ve supplied 2 million tonnes of coal. I can assure that there’ll be no shortage of coal for electricity production

– Union Coal Min Pralhad Joshi

An earthquake measuring 3.4 on the Richter scale occurred at East Kameng, Arunachal Pradesh at 1610 hours: National Center for Seismology (NCS)

Putin says ‘very important’ to ‘stabilise’ gas market

Shardul Thakur added to India’s main T20 World Cup squad

All-rounder Axar Patel, who was part of the 15-member squad will now be on the list of stand-by players: BCCI

India was one of 1st countries recognising Armenia’s independence & established diplomatic ties. Today, we did comprehensive review of our bilateral relations & discussed regional & multilateral issues. We agreed on road map for future cooperation

– EAM Dr S Jaishankar in Armenia

Rajnath Singh to address SCO webinar on Role of Women in Armed Forces

Session on ‘Historical Perspective of Women’s Roles in Combat Operations’ will be chaired by Dy Chief of IDS (Medical) Lt General Madhuri Kanitkar

Gold gains Rs 63; silver jumps Rs 371

Gold in the national capital on Wednesday rose Rs 63 to Rs 46,329 per 10 grams amid rally in international precious metal prices, according to HDFC Securities. Silver also jumped Rs 371 to Rs 60,788 per kg, from Rs 60,417 per kg in the previous trade.

Infosys Q2 net profit up 11.9 pc at Rs 5,421 crore; revenue rises 20.5 pc to Rs 29,602 crore: Co filing

Maharashtra Cabinet announces a package of Rs 10,000 cr to the farmers affected by heavy rains and floods

Rs 10,000/hectare assistance for agriculture, Rs 15,000/hectare for horticulture& Rs 25,000/hectare for perennial crops; aid to be provided up to a limit of 2 hectares land.

Mindtree Q2 PAT at Rs 398.9 cr vs Rs 343.4 cr QoQ

Infosys board approves dividend of Rs 15/share

Reports ET NOW

Wipro Q2 consolidated profit rises by 17{cfdf3f5372635aeb15fd3e2aecc7cb5d7150695e02bd72e0a44f1581164ad809} to Rs 2,930.6 cr, revenue up at Rs 19,667.4 cr

It’s good that Devendra Fadnavis still considers himself as CM. I congratulate him. After being CM for five years, Fadnavis still feels he is holding the post. I lacked this trait. I had served as CM (of Maharashtra) four times. But I don’t even remember

– NCP chief Sharad Pawar